PIPA5104511

BCAR3 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5104511-Each-of-1 In Stock ₹ 46,502.50

PIPA5104511 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

BCAR3

Classification

Polyclonal

Conjugate

Unconjugated

Gene

BCAR3

Gene Alias

AI131758; And34; AND-34; Bcar3; breast cancer anti-estrogen resistance 3; breast cancer antiestrogen resistance 3 protein; breast cancer anti-estrogen resistance protein 3; dJ1033H22.2 (breast cancer anti-estrogen resistance 3); KIAA0554; novel SH2-containing protein 2; NSP2; OTTHUMP00000011961; p130Cas-binding protein AND-34; SH2 domain-containing protein 3B; SH2D3B; UNQ271/PRO308

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

310838, 8412

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

O75815

Gene Symbols

BCAR3

Immunogen

A synthesized peptide derived from human BCAR3(Accession O75815), corresponding to amino acid residues M774-E824.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5104219

--

Img

Thermo Scientific

PIPA5101491

--

Img

Thermo Scientific

PIPA5104372

--

Img

Thermo Scientific

PIPA5101420

--

Img

Thermo Scientific

PIPA5104289

--

Img

Thermo Scientific

PIPA5104224

--

Img

Thermo Scientific

PIMA535829

--

Img

Thermo Scientific

PIPA5104267

--

Description

  • Antibody detects endogenous levels of total BCAR3
  • Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen
  • However, breast cancers progress to become anti-estrogen resistant
  • Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance
  • The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells
  • The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48.